Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Climent Agustín, Marta Carmenca
- dc.contributor.author Hidalgo, Nilsca
- dc.contributor.author Vidal, Óscarca
- dc.contributor.author Puig, Soniaca
- dc.contributor.author Iglesias García, Marca
- dc.contributor.author Cuatrecasas, Miriamca
- dc.contributor.author Ramón Moros, José Manuelca
- dc.contributor.author Garcia-Albéniz, Xabierca
- dc.contributor.author Grande Posa, Luísca
- dc.contributor.author Pera Roman, Manuel Ramónca
- dc.date.accessioned 2016-02-24T10:49:55Z
- dc.date.available 2017-01-31T03:00:05Z
- dc.date.issued 2016
- dc.description.abstract BACKGROUND: We assessed the impact of complications on recurrence and survival after curative gastric cancer resection. METHODS: Patients undergoing R0 resections between 1990 and 2009 were identified in a prospectively maintained database and were categorized by presence of any complication Clavien-Dindo (CD) ≥ II, sepsis or intra-abdominal sepsis. Cox regression analyses to relate complications and clinico-pathological variables to time to recurrence (TTR) and overall survival (OS) were performed. RESULTS: A total of 271 patients were included with a median follow-up of 149.9 months (range 140.1-159.9). complications CD ≥ II occurred in 162 (59.8%) patients, sepsis in 66 (22.5%), and intra-abdominal sepsis in 37 (13.6%). Recurrence developed in 88 (32.4%) patients. Independent predictors of short TTR were pTNM stage (IIIB-IIIC vs. IA-IIA) (hazard ratio [HR] = 37.55, 95% confidence interval [CI] 17.57-80.24; p < 0.001), D1 lymphadenectomy (HR = 3.14, 95% CI 1.94-5.07; p < 0.001), and male gender (HR = 1.65, 95% CI 1.06-2.57; p = 0.026). pTNM stage (IIIB-IIIC vs. IA-IIA, HR = 10.28, 95% CI 6.51-16.23; p < 0.001), male gender (HR = 1.64, 95% CI 1.17-2.31; p = 0.005), age (HR = 1.03, 95% CI 1.02-1.05; p < 0.001), and adjuvant therapy (HR = 0.55, 95% CI 0.37-0.83; p = 0.004) were identified as independent predictors of OS../nCONCLUSIONS: Evidence provided by this study does not support a negative impact of postoperative complications CD ≥ II, sepsis, and intra-abdominal sepsis on the oncologic outcome after curative gastric cancer resection.ca
- dc.format.mimetype application/pdfca
- dc.identifier.citation Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M. et al. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol. 2016 Jan;42(1):132-9. doi: 10.1016/j.ejso.2015.08.163.ca
- dc.identifier.doi http://dx.doi.org/10.1016/j.ejso.2015.08.163
- dc.identifier.issn 0748-7983
- dc.identifier.uri http://hdl.handle.net/10230/25940
- dc.language.iso engca
- dc.publisher Elsevierca
- dc.relation.ispartof European Journal of Surgical Oncology. 2016 Jan;42(1):132-9
- dc.rights c) 2015 Elsevier.Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M. et al. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol. 2016 Jan;42(1):132-9. doi: 10.1016/j.ejso.2015.08.163.ca
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.other Aparell digestiu -- Malaltiesca
- dc.subject.other Gastroenterologiaca
- dc.subject.other Aparell digestiu -- Càncerca
- dc.title Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.ca
- dc.type info:eu-repo/semantics/articleca
- dc.type.version info:eu-repo/semantics/acceptedVersionca